FDA lifts clinical hold on Ocugen's Covid-19 vaccine study; stock skyrockets
February 18, 2022 at 18:09 PM EST
The FDA in November temporarily put the brakes on Ocugen's plan to test Covaxin in the United States.
 |
||||||||||||
|
||||||||||||
| About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map | ||||||||||||
Photos copyright by Jay Graham Photographer
